The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

The gouty arthritis market has been experiencing notable growth and is set to continue this trend in the coming years. Here’s an overview of the current market dynamics, key trends, and future prospects.

Current Market Size and Growth

• 2023 Market Size: $3.21 billion
• 2024 Market Size: $3.44 billion (CAGR of 7.2%)
• 2028 Market Size: $4.57 billion (CAGR of 7.3%)

The market’s growth in recent years has been driven by several factors:

• High Prevalence of Chronic Diseases: An increase in chronic conditions has heightened the demand for gouty arthritis treatments.
• Increased Alcohol Intake: Alcohol consumption is a known risk factor for gout, contributing to the market’s growth.
• Aging Population: As the elderly population grows, so does the incidence of gouty arthritis.
• Acceptance of Enhanced Therapies: There is a growing acceptance of advanced regeneration therapies.
• Rising Healthcare Expenditure: Increased spending on healthcare services supports the market expansion.

Projected Market Growth and Trends

• Improvements in Healthcare Infrastructure: Better healthcare facilities and services are expected to boost market growth.
• Increased Obesity Rates: Obesity contributes to higher rates of gout, thereby expanding the market.
• Increased Incidence of Gout: The rising incidence of gout drives demand for effective treatments.
• Rising Awareness: Growing awareness among the public about gouty arthritis is contributing to market growth.

View More On The Gouty Arthritis Market Report 2024 – https://www.thebusinessresearchcompany.com/report/gouty-arthritis-global-market-report

Key Trends:

• Demand for Effective Treatments: There is a growing need for effective and innovative treatment options.
• Regenerative Therapies: Advances in regenerative medicine are impacting the treatment landscape.
• Technological Advancements: Innovations in medical technology are enhancing diagnosis and treatment options.
• Product Launches and Approvals: New product launches and regulatory approvals are shaping the market.

The Impact of Obesity

Obesity plays a significant role in the gouty arthritis market:

• Rising Obesity Rates: Increased consumption of high-calorie foods and sedentary lifestyles contribute to obesity.
• Link to Gout: Obesity increases uric acid production and reduces its excretion, leading to gouty arthritis.
• Market Influence: With around 1 billion individuals classified as obese globally, the rising rates of obesity are expected to drive market growth.

Innovations in Treatment

Cortrophin Gel:

• New Approval: In October 2023, ANI Pharmaceuticals received FDA approval for a new 1-mL vial of Cortrophin Gel, used for treating acute gouty arthritis flares.
• Unique Position: Cortrophin Gel is the only FDA-approved ACTH therapy for gouty arthritis flares.

Tigulixostat Development:

• Collaborative Effort: Innovent Biologics Inc. and LG Chem Life Sciences are developing Tigulixostat, a new non-purine xanthine oxidase inhibitor.
• Market Expansion: This collaboration aims to introduce Tigulixostat to the Chinese market, enhancing treatment options.

Market Segmentation

The gouty arthritis market is segmented as follows:

1. By Type:
   • Acute Gouty Arthritis
   • Chronic Gouty Arthritis
2. By Treatment:
   • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
   • Pain Relievers
   • Corticosteroids
   • Xanthine Oxidase Inhibitors
   • Uricosurics
   • Others
3. By Diagnosis:
   • Joint Fluid Test
   • Blood Test
   • X-Ray Imaging
   • Ultrasound
   • Dual Energy Computed Tomography (CT) Scan
   • Other Diagnostics
4. By Distribution Channel:
   • Hospital Pharmacy
   • Retail Pharmacy
   • Others
5. By End-Users:
   • Hospitals
   • Specialty Clinics
   • Others

Regional Insights

• North America: Dominated the gouty arthritis market in 2023.
• Europe: Expected to be the fastest-growing region in the forecast period.

The gouty arthritis market is poised for continued growth due to advancements in treatment options, increasing obesity rates, and improved healthcare infrastructure. The ongoing development of innovative therapies and the rising prevalence of the condition will further drive market expansion.

Request A Sample Of The Global Gouty Arthritis Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=16070&type=smp